Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis

Abstract

Background:

Peripapillary retinal nerve fibre layer (pRNFL) thickness is emerging as a marker of axonal degeneration in multiple sclerosis (MS).

Objective:

We aimed to prospectively assess the predictive value of pRNFL for progression of physical and cognitive disability in relapsing-remitting MS (RRMS).

Methods:

In this 3-year longitudinal study on 151 RRMS patients, pRNFL was measured by spectral-domain optical coherence tomography (OCT). We used proportional hazard models, correcting for age, sex, disease duration, Expanded Disability Status Scale (EDSS) and Symbol Digit Modalities Test (SDMT) at baseline, to test a pRNFL thickness ≤88 µm at baseline for prediction of EDSS progression and cognitive decline. We also evaluated the decrease in pRNFL thickness from baseline to year 3 in a multivariate linear regression model.

Results:

pRNFL thickness ≤88 µm was independently associated with a threefold increased risk of EDSS progression (p < 0.001) and a 2.7-fold increased risk of cognitive decline within the subsequent 3 years (p < 0.001). Mean pRNFL delta was −5.3 µm (SD, 4.2). It was significantly negatively impacted by EDSS progression, cognitive decline, higher age and disease duration, while positively impacted by disease-modifying therapy (DMT).

Conclusion:

Cross-sectional and longitudinal monitoring of pRNFL is useful as a biomarker for prediction of physical and cognitive disability progression in patients with RRMS in everyday clinical practice.

Keywords

Multiple sclerosis optical coherence tomography pRNFL disability progression cognitive decline

Get full access to this article

View all access options for this article.

References

Swanton

Fernando

Miller

Early prognosis of multiple sclerosis. Handb Clin Neurol 2014; 122: 371–391.

Green

McQuaid

Hauser

et al . Ocular pathology in multiple sclerosis: Retinal atrophy and inflammation irrespective of disease duration. Brain 2010; 133(Pt6): 1591–1601.

Abalo-Lojo

Limeres

Gómez

et al . Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients. J Neuroophthalmol 2014; 34(1): 23–28.

Ratchford

Saidha

Sotirchos

et al . Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 2013; 80(1): 47–54.

Saidha

Al-Louzi

Ratchford

et al . Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol 2015; 78(5): 801–813.

Coric

Balk

Verrijp

et al . Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Mult Scler 2018; 24: 158–166.

Toledo

Sepulcre

Salinas-Alaman

et al . Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler 2008; 14(7): 906–912.

Martínez-Lapiscina

Arnow

Wilson

et al . Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study. Lancet Neurol 2016; 15(6): 574–584.

Polman

Reingold

Banwell

et al . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292–302.

10.

Petzold

de Boer

Schippling

et al . Optical coherence tomography in multiple sclerosis: A systematic review and meta-analysis. Lancet Neurol 2010; 9(9): 921–932.

11.

Gabilondo

Martínez-Lapiscina

Fraga-Pumar

et al . Dynamics of retinal injury after acute optic neuritis. Ann Neurol 2015; 77(3): 517–528.

12.

Gabilondo

Martínez-Lapiscina

Martínez-Heras

et al . Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 2014; 75(1): 98–107.

13.

Schippling

Balk

Costello

et al . Quality control for retinal OCT in multiple sclerosis: Validation of the OSCAR-IB criteria. Mult Scler 2014; 21(2): 163–170.

14.

Poser

Paty

Scheinberg

et al . New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13(3): 227–231.

15.

Kurtzke

JF.

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444–1452.

16.

Benedict

Duquin

Jurgensen

et al . Repeated assessment of neuropsychological deficits in multiple sclerosis using the symbol digit modalities test and the MS neuropsychological screening questionnaire. Mult Scler 2008; 14(7): 940–946.

17.

Amato

Portaccio

Goretti

et al . Relevance of cognitive deterioration in early relapsing-remitting MS: A 3-year follow-up study. Mult Scler 2010; 16(12): 1474–1482.

18.

Benedict

DeLuca

Phillips

et al . Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler 2017; 23(5): 721–733.

19.

Saidha

Syc

Ibrahim

et al . Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134(Pt2): 518–533.

20.

Compston

Coles

Multiple sclerosis. Lancet 2002; 359(9313): 1221–1231.

21.

Graham

You

Yiannikas

et al . Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: A longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 2016; 57(4): 2311–2317.

22.

Serbecic

Aboul-Enein

Beutelspacher

et al . High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: The first follow up study over two years. PLoS ONE 2011; 6(5): e19843.

23.

Leung

CKS

Weinreb

et al . Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography. Ophthalmology 2012; 119(4): 731–737.

24.

Mansoori

Balakrishna

Effect of aging on retinal nerve fiber layer thickness in normal Asian Indian eyes: A longitudinal study. Ophthalmic Epidemiol 2017; 24(1): 24–28.

25.

Button

Al-Louzi

Lang

et al . Disease-modifying therapies modulate retinal atrophy in multiple sclerosis. Neurology 2017; 88(6): 525–532.

26.

Ontaneda

Fox

RJ.

Imaging as an outcome measure in multiple sclerosis. Neurotherapeutics 2017; 14: 24–34.

27.

Narayanan

Cheng

Bonem

et al . Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler 2014; 20(10): 1331–1341.

28.

Saidha

Sotirchos

et al . Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 2013; 70(1): 34–43.